Bispecific NKG2D-CD3 and NKG2D-CD16 Fusion Proteins as Novel Treatment Option in Advanced Soft Tissue Sarcomas.
双特异性 NKG2D-CD3 和 NKG2D-CD16 融合蛋白作为晚期软组织肉瘤的新型治疗选择
期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2021.653081
Hagelstein Ilona, Lutz Martina S, Schmidt Moritz, Heitmann Jonas S, Malenke Elke, Zhou Yanjun, Clar Kim L, Kopp Hans-Georg, Jung Gundram, Salih Helmut R, Märklin Melanie, Hinterleitner Clemens
